[ Price : $8.95]
FDA approves Fresenius Kabi and Formycons biosimilar Otulfi (ustekinumab-aauz), a copy of Johnson & Johnsons referenced Stelara.[ Price : $8.95]
Sen Bill Cassidy asks FDA to respond to questions about its decades-long failure to give Orange Book patent listing clarity to dru...[ Price : $8.95]
FDA warns East Rutherford, NJ-based Diamond Chemical about CGMP violations in the production of finished drugs.[ Price : $8.95]
FDA begins implementing a new model for FDA inspections as part of an agency-wide reorganization that was brought on by the 2022 i...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion says it will research how using an endorser to provide prescription drug informatio...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Electronic User Fee Payment Request Forms ...[ Price : $8.95]
After four deaths were reported, Kezar Life Sciences suspends the enrollment of new patients and dosing of ongoing patients in its...[ Price : $8.95]
Federal Register notice: FDA makes available four final device-specific guidance documents for the Safety and Performance Based Pa...